Document Detail


Sustained delivery of lidocaine into the cochlea using poly lactic/glycolic acid microparticles.
MedLine Citation:
PMID:  19950377     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES/HYPOTHESIS: Lidocaine is a local anesthetic that is known to suppress tinnitus via systemic or local application; however, this effect has only limited duration. The current study aimed to establish a method for the sustained delivery of lidocaine into the cochlea using poly lactic/glycolic acid (PLGA) microparticles. STUDY DESIGN: Experimental study. METHODS: Lidocaine-loaded PLGA microparticles were produced and their in vitro-release profiles were examined. The lidocaine concentrations in the perilymph were measured at different time points following the application of the lidocaine-loaded PLGA microparticles to the round-window membranes of guinea pigs. The possible adverse effects of the local application of lidocaine-loaded PLGA microparticles were also examined. RESULTS: The in vitro analyses revealed that the microparticles were capable of the sustained delivery of lidocaine. The in vivo experiments demonstrated the sustained delivery of lidocaine into the cochlear fluid, and the maintenance of high lidocaine concentrations in the perilymph for up to 3 days after application. Nystagmus and inflammation in the middle ear mucosa were not detected after the local application of lidocaine-loaded PLGA microparticles, although temporary hearing loss was observed. CONCLUSIONS: Lidocaine-loaded PLGA microparticles were shown to be capable of the sustained delivery of lidocaine into the cochlea, suggesting that they could be used for the attenuation of peripheral tinnitus.
Authors:
Rie T Horie; Tatsunori Sakamoto; Takayuki Nakagawa; Yasuhiko Tabata; Noboru Okamura; Naoki Tomiyama; Mitsuhiro Tachibana; Juichi Ito
Related Documents :
15997437 - Poly(lactide) stereocomplexes: formation, structure, properties, degradation, and appli...
10530197 - Crystal growth bonded composite restorations. a bond strength evaluation.
11720547 - Design and synthesis of photoresponsive poly(benzyl ester) dendrimers with all-azobenze...
4790587 - Studies on the toxicity and antiviral activity of various polynucleotides.
4208137 - Detachment and chemical characterization of the regularly arranged subunits from the su...
12375987 - Syntheses of chiral homoazacalix[4]arenes incorporating amino acid residues: molecular ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Laryngoscope     Volume:  120     ISSN:  1531-4995     ISO Abbreviation:  Laryngoscope     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-01-26     Completed Date:  2010-02-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8607378     Medline TA:  Laryngoscope     Country:  United States    
Other Details:
Languages:  eng     Pagination:  377-83     Citation Subset:  IM    
Affiliation:
Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anesthetics, Local / administration & dosage*,  adverse effects,  pharmacokinetics
Animals
Biocompatible Materials
Cochlea*
Drug Carriers* / adverse effects
Drug Delivery Systems*
Ear, Middle / drug effects,  pathology
Evoked Potentials, Auditory, Brain Stem / drug effects
Female
Guinea Pigs
Lactic Acid* / adverse effects
Lidocaine / administration & dosage*,  adverse effects,  pharmacokinetics
Microspheres
Polyglycolic Acid* / adverse effects
Surface Properties
Vestibular Function Tests
Chemical
Reg. No./Substance:
0/Anesthetics, Local; 0/Biocompatible Materials; 0/Drug Carriers; 0/polylactic acid-polyglycolic acid copolymer; 137-58-6/Lidocaine; 26009-03-0/Polyglycolic Acid; 50-21-5/Lactic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ergonomic analysis of microlaryngoscopy.
Next Document:  Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer.